Cargando…

Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease

Detalles Bibliográficos
Autores principales:	Hegarty, Shane V., Green, Holly F., Niclis, Jonathan, O'Keeffe, Gerard W., Sullivan, Aideen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325904/ https://www.ncbi.nlm.nih.gov/pubmed/32655345 http://dx.doi.org/10.3389/fnins.2020.00515

Ejemplares similares

The Epigenome as a therapeutic target for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2016)

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2014)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

Protocol for evaluation of neurotrophic strategies in Parkinson’s disease-related dopaminergic and sympathetic neurons in vitro
por: Hegarty, Shane V., et al.
Publicado: (2016)

Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease
por: O'Keeffe, Gerard W., et al.
Publicado: (2017)

Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease
por: Hegarty, Shane V., et al.
Publicado: (2018)

Neurotrophic factor therapy for Parkinson's disease: past, present and future
por: Sullivan, Aideen M., et al.
Publicado: (2016)

Diet quality, sleep and quality of life in Parkinson’s disease: a cross-sectional study
por: Dunk, Danielle, et al.
Publicado: (2022)

The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells
por: Alshangiti, Amnah M., et al.
Publicado: (2019)

The class II histone deacetylases as therapeutic targets for Parkinson’s disease
por: Mazzocchi, Martina, et al.
Publicado: (2020)

The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease
por: Goulding, Susan R., et al.
Publicado: (2020)

Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease
por: Costello, Daniel J, et al.
Publicado: (2012)

Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation
por: Hegarty, Shane V., et al.
Publicado: (2017)

4-Hydroxychalcone Induces Cell Death via Oxidative Stress in MYCN-Amplified Human Neuroblastoma Cells
por: Alshangiti, Amnah M., et al.
Publicado: (2019)

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease
por: Goulding, Susan R., et al.
Publicado: (2021)

MicroRNAs in the epigenetic regulation of disease progression in Parkinson’s disease
por: Selvakumar, Sushmaa Chandralekha, et al.
Publicado: (2022)

Association of distinct type 1 bone morphogenetic protein receptors with different molecular pathways and survival outcomes in neuroblastoma
por: Alshangiti, Amnah M., et al.
Publicado: (2020)

Epigenetics and MicroRNAs in Cancer
por: Ramassone, Alice, et al.
Publicado: (2018)

Alterations of epigenetics and microRNAs in cancer and cancer stem cell
por: Saito, Yoshimasa
Publicado: (2014)

Epigenetics and microRNAs in UGT1As
por: Meng, Cui-Lan, et al.
Publicado: (2021)

Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease
por: Collins, Louise M, et al.
Publicado: (2014)

Role of MicroRNAs in Parkinson’s Disease
por: Goh, Suh Yee, et al.
Publicado: (2019)

MicroRNAs: an emerging science in cancer epigenetics
por: Kala, Rishabh, et al.
Publicado: (2013)

MicroRNAs: Important Epigenetic Regulators in Osteoarthritis
por: Trzeciak, Tomasz, et al.
Publicado: (2014)

Epigenetic Regulation of Innate Immunity by microRNAs
por: Boosani, Chandra S., et al.
Publicado: (2016)

Advances with microRNAs in Parkinson’s disease research
por: Ma, Liuqing, et al.
Publicado: (2013)

MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus
por: Wang, Hsiuying
Publicado: (2021)

Ectopic microRNAs used to preserve human mesenchymal stem cell potency and epigenetics
por: Ghasemzadeh, Navid, et al.
Publicado: (2018)

Epigenetic Control of Autophagy by MicroRNAs in Ovarian Cancer
por: Titone, Rossella, et al.
Publicado: (2014)

Global Epigenetic Regulation of MicroRNAs in Multiple Myeloma
por: Zhang, Wenjing, et al.
Publicado: (2014)

Regulation of microRNAs by epigenetics and their interplay involved in cancer
por: Liu, Xiaolan, et al.
Publicado: (2013)

Epigenetic Therapy in Lung Cancer – Role of microRNAs
por: Rothschild, Sacha I.
Publicado: (2013)

MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer
por: Rahman, Mohammad Mijanur, et al.
Publicado: (2019)

The Transmission of Intergenerational Epigenetic Information by Sperm microRNAs
por: Lee, Grace S., et al.
Publicado: (2022)

Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated Atherosclerosis
por: Griñán, Raquel, et al.
Publicado: (2022)

Editorial: MicroRNAs as New Players in Endocrinology
por: Peng, Chun, et al.
Publicado: (2018)

Editorial: MicroRNAs in endocrinology and cell signaling
por: Peng, Chun, et al.
Publicado: (2022)

Editorial: MicroRNAs as biomarkers in colorectal cancer
por: Ulivi, Paola
Publicado: (2023)

MicroRNAs in Parkinson's disease and emerging therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2017)

Breast Cancer Epigenetics: From DNA Methylation to microRNAs
por: Veeck, Jürgen, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_diib2dl0erpjr2v3cp194rr9ei